/ 2020. The reason for the increase revenues due to increased sales of both domestic and international. Although it has the COVIC-19 epidemic situation, but still maintain a close relationship with

- Translation- June 11, 2019 Subject: Notification the Acquisition of share of BS Myco Biotech Company Limited. (Additional Information Memorandum Concerning the Acquisition of Assets) To: Director and Manager

million baht or 47.3 percent. Mainly due to the overall economic slowdown from the crisis situation from the epidemic of the Covid-19 virus, resulting in a reduced advertising expenditure in print media and

the Company having increased sales of products abroad. Despite the COVIC-19 epidemic situation, the company has maintained a close relationship with overseas customers through online systems. And the

, which is increased from the same period of last year by 5 million baht or 510.20 percent. Although this year there has been the COVID-19 epidemic situation affecting all industries across the country and

% EBIT (27.73) (3.27) (24.46) 748.01% Net Profit (Loss) (21.72) (0.34) (21.38) 6288.24% Basic Earnings (Loss) per Share (0.110) (0.002) (0.108) 6288.24% Performance Report The epidemic of COVID-19 affects

DOD BIOTECH PUBLIC COMPANY LIMITED เลขที ่111 หมู่ที ่2 ต ำบลท่ำจีน อ ำเภอเมืองสมุทรสำคร จังหวดัสมุทรสำคร 74000 111 Moo 2 TambonThachin, Amphurmuangsamutsakhon, Samutsakhon 74000 No. DOD089/2563

1,901.2 1,664.5 1,112.0 236.7 14.2 789.2 71.0 Profit for the period 136.9 121.3 50.4 15.6 12.9 86.5 171.6 Thai Economy in Q2–2021 was visibly affected by the third round of the COVID-19 epidemic. As the

the following factors: 1) gradual relaxation of COVID-19 epidemic control measures and progress in vaccination 2) the impact of outstanding demand from the previous quarter and 3) government policies

financial statements only.) Summary overview In the 1st quarter of 2020, the Company organized “ Thailand Mobile EXPO 2020” 35th , on February, 7- 10 2020. Although the event is in start phase of the epidemic